Algert Global’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Algert Global's GILD Position: Q1 2026 in Review
Algert Global sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 37,341 shares — an estimated $4.58M sold.
Algert Global first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $4.58M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Algert Global reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Algert Global sold 37,341 Gilead Sciences shares in Q1 2026, an estimated $4.58M.
- Algert Global first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
- Algert Global's Gilead Sciences position peaked at $4.58M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.